However, it needs further studies to explore whether enhancing the function of T-cells through inhibiting MDSC-derived ARG1 production could reduce the mortality and morbidity of AIDS-associated cryptococcal meningitis since these patients have very few CD4+T-cells and may not therefore be able to respond to our proposed T-cell mediated immunotherapy. This evidence concerns the gene ARG1 and Cryptococcal meningitis.